Brian Drachman

Development of metaverse for intelligent healthcare

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association

Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

The role of psychological science in efforts to improve cardiovascular medication adherence.

Design of amyloidogenic peptide traps

Peripartum cardiomyopathy

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

Mobile health in preventive cardiology: current status and future perspective

Systemic amyloidosis from A (AA) to T (ATTR): a review

Ionizable lipid nanoparticles for in utero mRNA delivery

Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis

Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction

A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis